Loading...

CSL Limited

CMXHF•PNK
Healthcare
Biotechnology
$173.54
$11.82(7.31%)

CSL Limited (CMXHF) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.7/100

Key Financials

Market Cap84B
P/E Ratio30.56
EPS (TTM)$5.46
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$164.56
1 Month$167.62
3 Months$161.89
1 Year Target$181.99

CMXHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CMXHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $181.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.56 and a market capitalization of 84B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;